VTEX Chief Revenue Officer Santiago Naranjo Alvarez filed a Form 4 on November 5, 2026, disclosing the acquisition of 100,000 Restricted Stock Units in Class A Common Shares with a transaction date of November 3, 2026.
Vontier Corporation filed its Form 10-Q for the quarterly period ended October 2, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting third-quarter sales of $736.9 million and net earnings of $99.0 million.
Aflac Incorporated filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three- and nine-month periods ended September 30, 2026, disclosing a sharp decline in quarterly net earnings driven by significant net investment losses.
Director Craig H. Barratt filed a Form 4 with the SEC on November 5, 2026, disclosing the exercise of 1,150 non-qualified stock options and the same-day sale of 1,150 shares of Intuitive Surgical Inc (NASDAQ:ISRG) common stock on November 4, 2026, under a Rule …
Curaleaf Holdings, Inc. filed a current report on November 5, 2026, disclosing that on November 3, 2026, the company issued a statement regarding an alternative proposal for Aurora Cannabis.
Director Todd B. Urness filed a Form 144 notice on November 5, 2026, disclosing a proposed sale of 20,000 shares of Bridgewater Bancshares Inc common stock with an aggregate market value of $405,000.00.
Primo Brands Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting a condensed consolidated balance sheet showing total assets of $10,828.0 million.
Flutter Entertainment plc's Group Chief Executive Officer, Daniel Mark Taylor, filed a Form 144 notice on November 5, 2026, disclosing a proposed sale of 3,727 ordinary shares following the vesting of equity awards.
Richard Paul Strommer, an officer of Greenlight Capital Re, Ltd., filed a Form 144 notice of proposed sale on November 5, 2026, disclosing plans to sell 25,000 shares of common stock through Charles Schwab Corp.
Curaleaf Holdings, Inc. filed a Form 8-K on November 5, 2026, disclosing that on November 3, 2026, the company issued a statement regarding an alternative proposal for Aurora Cannabis, with the press release attached as Exhibit 99.1.